Nanitebio
Boston, US · Founded 2020 · 15 employees on LinkedIn · 2 known investors
Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.
Founders & leadership
Nanitebio was founded in 2020 by Shashi Murthy, Sean Kevlahan, and Thomas Neenan.
Investors · 2
Reported raises · per SEC filings
Form D private placements$4.1M disclosed across 1 round · 2022
▶$4.1MraisedMay 2022 · 11 investors · Other TechnologyRule 506(b)
▶$4.1MraisedMay 2022 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Shashi MurthyExecutive Officer
- Sean KevlahanExecutive Officer, Director, Promoter
- Thomas X. NeenanExecutive Officer
- Offering amount
- $6.1M
- Amount sold
- $4.1M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Nanitebio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nanitebio do?
- Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.
- Who founded Nanitebio?
- Nanitebio was founded by Shashi Murthy, Sean Kevlahan, Thomas Neenan in 2020.
- Who are Nanitebio's investors?
- Nanitebio's investors include Bantam Group, Civilization Ventures Management, Llc.
- How much funding has Nanitebio raised?
- Nanitebio has disclosed $4.1M raised across 1 round.
- Where is Nanitebio headquartered?
- Nanitebio is headquartered in Boston, US.